Cargando…

Deciphering Multiple Sclerosis Progression

Multiple sclerosis (MS) is primarily an inflammatory and degenerative disease of the central nervous system, triggered by unknown environmental factors in patients with predisposing genetic risk profiles. The prevention of neurological disability is one of the essential goals to be achieved in a pat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Meca-Lallana, Virginia, Berenguer-Ruiz, Leticia, Carreres-Polo, Joan, Eichau-Madueño, Sara, Ferrer-Lozano, Jaime, Forero, Lucía, Higueras, Yolanda, Téllez Lara, Nieves, Vidal-Jordana, Angela, Pérez-Miralles, Francisco Carlos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Neurology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8058428/ https://www.ncbi.nlm.nih.gov/pubmed/33897583 http://dx.doi.org/10.3389/fneur.2021.608491

Ejemplares similares

Cognitive impairment in multiple sclerosis: diagnosis and monitoring
por: Meca-Lallana, Virginia, et al.
Publicado: (2021)

Brain region volumes and their relationship with disability progression and cognitive function in primary progressive multiple sclerosis
por: Pérez‐Miralles, Francisco Carlos, et al.
Publicado: (2021)

Information-Seeking Strategies of People with Multiple Sclerosis in Spain: The INFOSEEK-MS Study
por: Higueras, Yolanda, et al.
Publicado: (2022)

Assessing fatigue in multiple sclerosis: Psychometric properties of the five-item Modified Fatigue Impact Scale (MFIS-5)
por: Meca-Lallana, Virginia, et al.
Publicado: (2019)

Gender Gap in the Leadership of Health Institutions: The Influence of Hospital-Level Factors
por: Pérez-Sánchez, Soledad, et al.
Publicado: (2021)

Spanish real-world experience with fingolimod in relapsing-remitting multiple sclerosis patients: MS NEXT study
por: Barrero, Francisco, et al.
Publicado: (2020)

XV Reunión Post-ECTRIMS: revisión de las novedades presentadas en el Congreso ECTRIMS 2022 (II)
por: Fernández, Óscar, et al.
Publicado: (2023)

XV Reunión Post-ECTRIMS: revisión de las novedades presentadas en el Congreso ECTRIMS 2022 (I)
por: Fernández, Óscar, et al.
Publicado: (2023)

A Pilot Study to Explore Patient Satisfaction With a Virtual Rehabilitation Program in Multiple Sclerosis: The RehabVR Study Protocol
por: Meca-Lallana, Virginia, et al.
Publicado: (2020)

Impact of Neuromyelitis Optica Spectrum Disorder on Quality of Life from the Patients’ Perspective: An Observational Cross-Sectional Study
por: Meca-Lallana, José E., et al.
Publicado: (2022)

COVID-19 in 7 multiple sclerosis patients in treatment with ANTI-CD20 therapies
por: Meca-Lallana, Virginia, et al.
Publicado: (2020)

Cognitive Performance and Health-Related Quality of Life in Patients with Neuromyelitis Optica Spectrum Disorder
por: Lopez-Soley, Elisabet, et al.
Publicado: (2022)

Disability and Fatigue in Multiple Sclerosis: Can Rehabilitation Improve Them through a Structured Retraining Program?
por: Arriaza, María José, et al.
Publicado: (2022)

Quantifying the patient´s perspective in neuromyelitis optica spectrum disorder: Psychometric properties of the SymptoMScreen questionnaire
por: Meca-Lallana, José E., et al.
Publicado: (2021)

Covid-19 in a patient with multiple sclerosis treated with natalizumab: May the blockade of integrins have a protective role?
por: Aguirre, Clara, et al.
Publicado: (2020)

Restricción transitoria de la difusión en resonancia magnética debido a degeneración transneuronal del cuerpo estriado
por: Belloch-Ripollés, Vicente, et al.
Publicado: (2022)

Transient reduced diffusion on magnetic resonance imaging due to transneuronal degeneration of the striatum
por: Belloch-Ripollés, Vicente, et al.
Publicado: (2022)

Perception of Stigma in Patients with Neuromyelitis Optica Spectrum Disorder
por: Meca-Lallana, Jose E, et al.
Publicado: (2021)

Spasticity in multiple sclerosis and role of glatiramer acetate treatment
por: Meca-Lallana, Jose Eustasio, et al.
Publicado: (2015)

Cognitive Dysfunctions and Assessments in Multiple Sclerosis
por: Oreja-Guevara, Celia, et al.
Publicado: (2019)

Efficacy of diet on fatigue, quality of life and disability status in multiple sclerosis patients: rapid review and meta-analysis of randomized controlled trials
por: Guerrero Aznar, María Dolores, et al.
Publicado: (2022)

Cost analysis of glatiramer acetate versus interferon-β for relapsing-remitting multiple sclerosis in patients with spasticity: the Escala study
por: Sánchez-de la Rosa, Rainel, et al.
Publicado: (2015)

Consensus on early detection of disease progression in patients with multiple sclerosis
por: Meca-Lallana, José E., et al.
Publicado: (2022)

Establishment of a safety protocol for the administration of treatments in multiple sclerosis during the SARS-CoV-2 pandemic
por: Meca-Lallana, Virginia, et al.
Publicado: (2020)

Perception of stigma in patients with primary progressive multiple sclerosis
por: Pérez-Miralles, Francisco, et al.
Publicado: (2019)

Four-year safety and effectiveness data from patients with multiple sclerosis treated with fingolimod: The Spanish GILENYA registry
por: Meca-Lallana, J. E., et al.
Publicado: (2021)

Deciphering Pathways for Carotenogenesis in Haloarchaea
por: Giani, Micaela, et al.
Publicado: (2020)

Deciphering multiple sclerosis disability with deep learning attention maps on clinical MRI
por: Coll, Llucia, et al.
Publicado: (2023)

Baseline Inflammatory Status Reveals Dichotomic Immune Mechanisms Involved In Primary-Progressive Multiple Sclerosis Pathology
por: Fernández-Velasco, José I., et al.
Publicado: (2022)

Data of preparation and evaluation of supramolecular hydrogel based on cellulose for sustained release of therapeutic substances with antimicrobial and wound healing properties
por: Marican, Adolfo, et al.
Publicado: (2020)

Progressive Demyelination in the Presence of Serum Myelin Oligodendrocyte Glycoprotein-IgG: A Case Report
por: Gil-Perotin, Sara, et al.
Publicado: (2018)

Effect of Ocrelizumab in Blood Leukocytes of Patients With Primary Progressive MS
por: Fernández-Velasco, José I., et al.
Publicado: (2021)

SARS-CoV-2 Infection in Multiple Sclerosis: Results of the Spanish Neurology Society Registry
por: Arrambide, Georgina, et al.
Publicado: (2021)

Analysis of humoral and cellular immunity after SARS-CoV-2 vaccination in patients with multiple sclerosis treated with immunomodulatory drugs
por: Meca-Lallana, Virginia, et al.
Publicado: (2023)

Psychometric Properties of the SymptoMScreen Questionnaire in a Mild Disability Population of Patients with Relapsing–Remitting Multiple Sclerosis: Quantifying the Patient’s Perspective
por: Meca-Lallana, José, et al.
Publicado: (2020)

Deciphering the Action of Perfluorohexyloctane Eye Drops to Reduce Ocular Discomfort and Pain
por: Delicado-Miralles, Miguel, et al.
Publicado: (2021)

Decipher
por: Pavlou, S
Publicado: (2001)

Decipher
Publicado: (2002)

Prior treatment status: impact on the efficacy and safety of teriflunomide in multiple sclerosis
por: Comi, Giancarlo, et al.
Publicado: (2020)

Family Planning in Fertile-Age Patients With Multiple Sclerosis (MS) (ConPlanEM Study): Delphi Consensus Statements
por: Oreja-Guevara, Celia, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_4rro4qcqq1gofiquodsjcrhn78